NCT07300319

Brief Summary

The goal of this randomized controlled study is to investigate the impact of chiropractic care on CCRF (Chronic Cancer Related Fatigue) and other health-related challenges that burden cancer survivors.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
12mo left

Started Feb 2027

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 10, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 23, 2025

Completed
1.1 years until next milestone

Study Start

First participant enrolled

February 1, 2027

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2028

Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

December 10, 2025

Last Update Submit

March 25, 2026

Conditions

Keywords

CancerFatigueChiropractic CareDelayed Start

Outcome Measures

Primary Outcomes (5)

  • Number of Eligible Randomized Participants

    The proportion of eligible participants randomized into the study

    2 years

  • Number of Participants Who Adhere to Study

    Proportion of enrolled participants who adhere to the pre-baseline assessment lifestyle restrictions as instructed. This assesses compliance.

    2 years

  • Number of Participants That Can Fulfill Study Activities

    Proportion of participants that can fulfill the given baseline assessment as directed. This assesses tolerability

    2 years

  • Number of Participants Who Chiropractic Sessions

    Proportion of randomized adults attending ≥90% of chiro sessions within 7 days of the prescribed time frame. This assesses adherence to treatment.

    2 years

  • Number of Enrolled Intervention Group Participants

    Proportion of the immediate-start group attending the final assessment session. This assesses retention.

    2 years

Study Arms (2)

Delayed Group

ACTIVE COMPARATOR

After the 6-week lab assessments, the participants in the delayed group will be offered 6 weeks of chiropractic care.

Other: Delayed Chiropractic Care

Immediate Group

EXPERIMENTAL

After the baseline assessment, the participants in the intervention group will receive 12 weeks of chiropractic care.

Other: Immediate Chiropractic Care

Interventions

Participants in the immediate start group will be assigned to chiropractic care for 12 weeks. Participants will have their upper cervical spine (C1/C2) assessed for the presence of vertebral subluxations per the chiropractor's normal and customary procedures and adjusted if necessary.

Immediate Group

Participants in the delayed start group will be assigned to chiropractic care for 6 weeks. Participants will have their upper cervical spine (C1/C2) assessed for the presence of vertebral subluxations per the chiropractor's normal and customary procedures and adjusted if necessary.

Delayed Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age.
  • Self-report that they have been informed by their primary health care provider that they are cancer-free (this is sometimes referred to as 'complete remission' or 'cured').
  • Minimum of 3 months since the completion of their primary curative-intent cancer therapies including surgery, chemotherapy, radiotherapy, and/or immunotherapy (long-term hormone therapy permitted)
  • Scores in the moderate-to-severe range (i.e., at or above the 60th percentile) on the FACIT-Fatigue scale.
  • Fatigue onset was at some point during their illness/treatment \& negatively impacts their quality of life \& daily functioning.

You may not qualify if:

  • Chiropractic care within the past 2 weeks
  • Taking short-acting benzodiazepines which include midazolam/Versed \& triazolam/Halcion.
  • Taking GLP-1 medications
  • Taking other types of prescription medications (including hormone therapy) and hasn't been on a stable dose for a minimum of 6 weeks with plans to change medications or doses during the study.
  • Disorders that cause fainting during rapid postural changes (e.g., POTS, orthostatic hypotension).
  • Not able to make a fist or grip objects with one or both hands
  • Deaf in one or both ears (hearing aids are ok)
  • Heart conditions, including pacemakers, which impact heart function
  • Diagnosed with rheumatoid arthritis, osteoporosis, or medically diagnosed cervical spine instability.
  • Current litigation related to a physical, health-related injury.
  • Pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Chiropractic Research

Marietta, Georgia, 30060, United States

Location

MeSH Terms

Conditions

NeoplasmsFatigue

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Tyson Perez, DC, PhD

    Life University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 10, 2025

First Posted

December 23, 2025

Study Start (Estimated)

February 1, 2027

Primary Completion (Estimated)

February 1, 2028

Study Completion (Estimated)

February 1, 2028

Last Updated

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations